N-(5-(((7-Methyl-4-oxo-1,4-dihydroquinolin-2-yl)methyl)thio)-1,3,4-thiadiazol-2-yl)butyramide

Catalog No. :
ACPCHH281
CAS No. :
933249-79-7
Molecular Formula :
C17H18N4O2S2
Molecular Weight :
374.49

IUPAC Name:N-(5-(((7-methyl-4-oxo-1,4-dihydroquinolin-2-yl)methyl)thio)-1,3,4-thiadiazol-2-yl)butyramide

N-(5-(((7-Methyl-4-oxo-1,4-dihydroquinolin-2-yl)methyl)thio)-1,3,4-thiadiazol-2-yl)butyramide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(5-(((7-Methyl-4-oxo-1,4-dihydroquinolin-2-yl)methyl)thio)-1,3,4-thiadiazol-2-yl)butyramide
IUPAC NameN-(5-(((7-methyl-4-oxo-1,4-dihydroquinolin-2-yl)methyl)thio)-1,3,4-thiadiazol-2-yl)butyramide
Molecular FormulaC17H18N4O2S2
Molecular Weight374.49
SMILESCCCC(NC1=NN=C(SCC(NC2=C3C=CC(C)=C2)=CC3=O)S1)=O
InChI KeyYEZCBRLLUQBRIV-UHFFFAOYSA-N
SynonymButanamide, N-[5-[[(1,4-dihydro-7-methyl-4-oxo-2-quinolinyl)methyl]thio]-1,3,4-thiadiazol-2-yl]-
CAS No.933249-79-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPCHH281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPCHH281 route product structure diagram
    ACPCHH281933249-79-7
Inquiry

2. ACPCHH281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPCHH281 route product structure diagram
    ACPCHH281933249-79-7
Inquiry

Comments (0)